ADVERTISEMENT
Glass dishes of blue liquid
Study Finds Reproducibility Issues in High-Impact Cancer Papers
Researchers involved in an eight-year project to reproduce the findings of more than 50 high-impact papers struggled to get enough information to even carry out most of the experiments.
Study Finds Reproducibility Issues in High-Impact Cancer Papers
Study Finds Reproducibility Issues in High-Impact Cancer Papers

Researchers involved in an eight-year project to reproduce the findings of more than 50 high-impact papers struggled to get enough information to even carry out most of the experiments.

Researchers involved in an eight-year project to reproduce the findings of more than 50 high-impact papers struggled to get enough information to even carry out most of the experiments.

science publishing, cancer

Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018 | 1 min read
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
Oncotarget Journal Cut from Medline
Katarina Zimmer | Oct 26, 2017 | 2 min read
New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.
Peer-Review Fraud Scheme Uncovered in China
Bob Grant | Jul 31, 2017 | 2 min read
The Chinese government finds almost 500 researchers guilty of misconduct in relation to a recent spate of retractions from a cancer journal.
Speaking of Science: 2016
Bob Grant | Dec 19, 2016 | 2 min read
Selected quotes from an eventful year
Speaking of Science
The Scientist | Apr 1, 2016 | 2 min read
April 2016's selection of notable quotes
TS Picks: December 3, 2015
Jef Akst | Dec 3, 2015 | 2 min read
Inducing brain infections to cure cancer?; new journal publishes bit science; priming the brain for language learning
Speaking of Science
The Scientist | Oct 1, 2015 | 2 min read
October 2015's selection of notable quotes
Dealing with Irreproducibility
Jef Akst | Apr 8, 2014 | 3 min read
Researchers discuss the growing pressures that are driving increases in retraction rates at AACR.
Opinion: Confounded Cancer Markers
Vincent Detours | Dec 7, 2011 | 3 min read
Prognostic signatures have become popular tools in cancer research, but it turns out signatures made of random genes are prognostic as well.
Medical Publishing for an N of One
George D. Lundberg | Apr 1, 2011 | 3 min read
New technologies and mind-sets are required for information delivery in the age of genomics.
ADVERTISEMENT